Managing your healthcare can get more complicated as you age, especially with inflammatory bowel disease. Here’s what experts ...

In successful clinical trials of drugs for inflammatory bowel disease (IBD), patients who received a placebo were at significantly higher risk for potential harms, according to two systematic reviews.

Low FODMAP and low-fat diets are associated with improvement in disease severity and QOL in IBD but may not be linked to microbiota profiles. Diet and microbiota have inconsistent associations in ...

Statin use in patients with moderate-to-severe inflammatory bowel disease (IBD) was associated with a 49% lower odds of IBD-related surgery, a retrospective study found. (Inflammatory Bowel Diseases) ...

Please provide your email address to receive an email when new articles are posted on . Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn’s disease, presents a complex ...

Certain patients with inflammatory bowel disease, which includes ulcerative colitis and Crohn’s disease of the colon, have an increased risk of developing colorectal cancer compared to individuals ...

Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, remains a major clinical challenge owing to its complex pathophysiology and clinical management: it is a ...

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid ...

Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...

Three physicians have earned the annual Bruce and Cynthia Sherman Charitable Foundation Sherman Prizes, which recognize excellence in the field of inflammatory bowel diseases. The 2024 Sherman prize ...